Graft-versus-leukemia reactions after bone marrow transplantation
To determine whether graft-versus-leukemia (GVL) reactions are important in preventing
leukemia recurrence after bone marrow transplantation, we studied 2,254 persons receiving …
leukemia recurrence after bone marrow transplantation, we studied 2,254 persons receiving …
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party …
HJ Kolb, A Schattenberg, JM Goldman, B Hertenstein… - 1995 - ashpublications.org
The immune reactivity of allogeneic lymphocytes plays a major role in the control of
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …
[HTML][HTML] Solid cancers after bone marrow transplantation
…, GE Sale, R Storb, WD Travis, HJ Kolb… - … England Journal of …, 1997 - Mass Medical Soc
Background The late effects of bone marrow transplantation, including cancer, need to be
determined in a large population at risk. Methods We studied 19,229 patients who received …
determined in a large population at risk. Methods We studied 19,229 patients who received …
Graft-versus-leukemia effects of transplantation and donor lymphocytes
HJ Kolb - Blood, The Journal of the American Society of …, 2008 - ashpublications.org
Allogeneic transplantation of hematopoietic cells is an effective treatment of leukemia, even
in advanced stages. Allogeneic lymphocytes produce a strong graft-versus-leukemia (GVL) …
in advanced stages. Allogeneic lymphocytes produce a strong graft-versus-leukemia (GVL) …
[HTML][HTML] Long-term survival and late deaths after allogeneic bone marrow transplantation
…, PA Rowlings, HC Schouten, HJ Kolb… - … England Journal of …, 1999 - Mass Medical Soc
Background and Methods It is uncertain whether mortality rates among patients who have
undergone bone marrow transplantation return to the level of the mortality rates of the general …
undergone bone marrow transplantation return to the level of the mortality rates of the general …
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a …
…, V Koza, M Bornhäuser, H Einsele, HJ Kolb… - The lancet …, 2009 - thelancet.com
Background Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality
after allogeneic haematopoietic cell transplantation from unrelated donors. Anti-T-cell …
after allogeneic haematopoietic cell transplantation from unrelated donors. Anti-T-cell …
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study
…, DA Shriner, DJ Weisdorf, HJ Kolb… - Blood, The Journal …, 1999 - ashpublications.org
We evaluated 18,014 patients who underwent allogeneic bone marrow transplantation (BMT)
at 235 centers worldwide to examine the incidence of and risk factors for posttransplant …
at 235 centers worldwide to examine the incidence of and risk factors for posttransplant …
[PDF][PDF] Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings
…, JM Hows, N Jacobsen, HJ Kolb… - Journal of clinical …, 1997 - academia.edu
Purpose: To compare outcomes of bone marrow transplants for leukemia from HLA-identical
siblings, haploidentical HLA-mismatched relatives, and HLA-matched and mismatched …
siblings, haploidentical HLA-mismatched relatives, and HLA-matched and mismatched …
Graft-versus-leukemia reactions in allogeneic chimeras
HJ Kolb, C Schmid, AJ Barrett, DJ Schendel - Blood, 2004 - ashpublications.org
There is a strong graft-versus-leukemia (GVL) effect of allogeneic stem cell transplantation (SCT)
due to elimination of tumor cells by alloimmune effector lymphocytes. When leukemia …
due to elimination of tumor cells by alloimmune effector lymphocytes. When leukemia …
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a …
…, G Ehninger, E Polge, NC Gorin, HJ Kolb… - Journal of clinical …, 2007 - ascopubs.org
Purpose To evaluate the role of donor lymphocyte infusion (DLI) in the treatment of relapsed
acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (…
acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (…